10 Results for "

SMC3

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "SMC3" in MCE Product Catalog:

Cat. No.: HY-RS18370
Research Areas:  

Others

Smc3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Smc3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS13419
Research Areas:  

Others

SMC3 Human Pre-designed siRNA Set A contains three designed siRNAs for SMC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24849
Research Areas:  

Others

Smc3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Smc3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-158308
Target:  

HDAC

Research Areas:  

Cancer

HDAC6-IN-41 (Compound E24) is a selective inhibitor for histone deacetylase 6 (HDAC6), with IC50 of 14 and 422 nM, for HDAC6 and HDAC8, respectively. HDAC6-IN-41 upregulates the acetylation of α-tubulin and histone site SMC3 .
loading...
    loading...
Cat. No.: HY-P82806
Synonyms: SMC protein 3; Bamacan; SMC3; BAM; BMH; CSPG6; SMC3L1

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-181979
Target:  

HDAC Apoptosis

Research Areas:  

Neurological Disease Cancer

HDAC8-IN-15 is a selective HDAC8 inhibitor with an IC50 of 0.40 μM. HDAC8-IN-15 increases the acetylation level of the HDAC8 substrate SMC3 without altering the total protein level of SMC3. HDAC8-IN-15 reduces cancer cell viability, inhibits colony formation, slows cell migration, induces apoptosis, and causes cell cycle arrest at the SubG1 phase. HDAC8-IN-15 can be used in studies related to neuroblastoma .
loading...
    loading...
Cat. No.: HY-P87713

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-181024
Target:  

PROTACs HDAC

Research Areas:  

Cancer

PROTAC HDAC8 Degrader-3 (Compound BP6) is an efficient, selective and low-toxicity HDAC8 PROTAC degrader with a DC50 of 80 nM. PROTAC HDAC8 Degrader-3 exhibits IC50 of PROTAC for HDAC8 and CRBN of 0.26 and 30 μM respectively. PROTAC HDAC8 Degrader-3 increases the level of Ac-SMC3, stabilizes p53 and sensitizes targeted reagents (such as Idasanutlin (HY-15676)), demonstrating its great potential in combination therapy .
loading...
    loading...
Cat. No.: HY-150772
CAS No.: 2413587-26-3
Tubulin/HDAC-IN-1 is a dual tubulin and HDAC-IN-1 inhibitor through CH/π interaction with tubulin and hydrogen bond interaction with HDAC8. Tubulin/HDAC-IN-1 inhibits tubulin polymerization and selectively inhibits HDAC8 (IC50: 150 nM). Tubulin/HDAC-IN-1 has cytotoxicity against various human cancer cells, also arrests cell cycle in the G2/M phase and induces cell apoptosis. Tubulin/HDAC-IN-1 can be used in the research of hematologic and solid tumors such as neuroblastoma, leukemia .
loading...
    loading...
Cat. No.: HY-182035
CAS No.: 2464465-06-1
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC8-IN-16 is a selective histone deacetylase 8 (HDAC8) inhibitor with an IC50 of 0.16 μM. HDAC8-IN-16 induces cell apoptosis, triggers G2/M phase cell cycle arrest, and moderately inhibits cancer cell proliferation. HDAC8-IN-16 is applicable to relevant research on colorectal cancer .
loading...
    loading...